Home »
Academic Articles »
C »
High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification
High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification
Scott Mastromatteo
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada)
Angela Chen
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada)
Jiafen Gong
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada)
Fan Lin
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada)
Bhooma Thiruvahindrapuram
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada)
Wilson W.L. Sung
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada)
Joe Whitney
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada)
Zhuozhi Wang
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada)
Rohan V. Patel
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada)
Katherine Keenan
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada)
Anat Halevy
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada)
Naim Panjwani
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada)
Julie Avolio
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada)
Cheng Wang
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada)
Guillaume Côté-Maurais
(Centre de recherche du centre hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada)
Stéphanie Bégin
(Centre de recherche du centre hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada)
Damien Adam
(Centre de recherche du centre hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada)
Emmanuelle Brochiero
(Centre de recherche du centre hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada)
Candice Bjornson
(Alberta Children’s Hospital, Calgary, AB, Canada)
Mark Chilvers
(British Columbia Children’s Hospital, Vancouver, BC, Canada)
April Price
(The Children’s Hospital, London Health Science Centre, London, ON, Canada)
Michael Parkins
(University of Calgary, Department of Medicine, Calgary, AB, Canada)
Richard van Wylick
(Kingston Health Sciences Centre, Kingston, ON, Canada)
Dimas Mateos-Corral
(IWK Health Centre, Halifax, NS, Canada)
Daniel Hughes
(IWK Health Centre, Halifax, NS, Canada)
Mary Jane Smith
(Memorial University of Newfoundland, Faculty of Medicine, St. John’s, NL, Canada)
Nancy Morrison
(Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada)
Elizabeth Tullis
(St. Michael’s Hospital, Toronto, ON, Canada)
Anne L. Stephenson
(St. Michael’s Hospital, Toronto, ON, Canada)
Pearce Wilcox
(St. Paul’s Hospital, Vancouver, BC, Canada)
Bradley S. Quon
(St. Paul’s Hospital, Vancouver, BC, Canada)
Winnie M. Leung
(University of Alberta Hospital, Edmonton, AB, Canada)
Melinda Solomon
(Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada)
Lei Sun
(Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada; Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada)
Felix Ratjen
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; Department of Paediatrics, University of Toronto, Toronto, ON, Canada)
Lisa J. Strug
(Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada; Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada; Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Department of Computer Science, University of Toronto, Toronto, ON, Canada; Corresponding author)
Summary: Phasing of heterozygous alleles is critical for interpretation of cis-effects of disease-relevant variation. We sequenced 477 individuals with cystic fibrosis (CF) using linked-read sequencing, which display an average phase block N50 of 4.39 Mb. We use these samples to construct a graph representation of CFTR haplotypes, demonstrating its utility for understanding complex CF alleles. These are visualized in a Web app, CFTbaRcodes, that enables interactive exploration of CFTR haplotypes present in this cohort. We perform fine-mapping and phasing of the chr7q35 trypsinogen locus associated with CF meconium ileus, an intestinal obstruction at birth associated with more severe CF outcomes and pancreatic disease. A 20-kb deletion polymorphism and a PRSS2 missense variant p.Thr8Ile (rs62473563) are shown to independently contribute to meconium ileus risk (p = 0.0028, p = 0.011, respectively) and are PRSS2 pancreas eQTLs (p = 9.5 × 10−7 and p = 1.4 × 10−4, respectively), suggesting the mechanism by which these polymorphisms contribute to CF. The phase information from linked reads provides a putative causal explanation for variation at a CF-relevant locus, which also has implications for the genetic basis of non-CF pancreatitis, to which this locus has been reported to contribute.